TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
TAKEDA PHARMACEUTICAL CO LTD
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026
$19.61−0.06 (-0.31%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Mar 31, 2026
Total debt
¥4.88T
¥512.16B due within a year
Net debt
¥4.29T
After ¥595.05B of cash
Implied interest rate
7.61%
FY2026 interest ÷ average debt
Interest coverage
0.0×
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, JPY
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Takeda Pharmaceutical's annual report. Trading prices and yields need FINRA TRACE data.